Philippe Amouyal - Net Worth and Insider Trading

Philippe Amouyal Net Worth

The estimated net worth of Philippe Amouyal is at least $3 Million dollars as of 2024-11-13. Philippe Amouyal is the Director of Cava Group Inc and owns about 15,000 shares of Cava Group Inc (CAVA) stock worth over $2 Million. Philippe Amouyal is the Director of Lexicon Pharmaceuticals Inc and owns about 240,332 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $285,995. Philippe Amouyal is also the Director of WW International Inc and owns about 46,769 shares of WW International Inc (WW) stock worth over $47,704. Details can be seen in Philippe Amouyal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Philippe Amouyal has not made any transactions after 2023-11-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Philippe Amouyal

To

Philippe Amouyal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Philippe Amouyal owns 4 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , WW International Inc (WW) , and Blue Buffalo Pet Products Inc (BUFF) among others .

Click here to see the complete history of Philippe Amouyal’s form 4 insider trades.

Insider Ownership Summary of Philippe Amouyal

Ticker Comapny Transaction Date Type of Owner
LXRX Lexicon Pharmaceuticals Inc 2023-11-13 director
WW WW International Inc 2018-08-31 director
BUFF Blue Buffalo Pet Products Inc 2018-04-24 director
LIMIT LIMIT 2023-11-17 director

Philippe Amouyal Latest Holdings Summary

Philippe Amouyal currently owns a total of 3 stocks. Among these stocks, Philippe Amouyal owns 15,000 shares of Cava Group Inc (CAVA) as of November 17, 2023, with a value of $2 Million and a weighting of 86.7%. Philippe Amouyal owns 240,332 shares of Lexicon Pharmaceuticals Inc (LXRX) as of November 13, 2023, with a value of $285,995 and a weighting of 11.4%. Philippe Amouyal also owns 46,769 shares of WW International Inc (WW) as of August 31, 2018, with a value of $47,704 and a weighting of 1.9%.

Latest Holdings of Philippe Amouyal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CAVA Cava Group Inc 2023-11-17 15,000 145.03 2,175,450
LXRX Lexicon Pharmaceuticals Inc 2023-11-13 240,332 1.19 285,995
WW WW International Inc 2018-08-31 46,769 1.02 47,704

Holding Weightings of Philippe Amouyal


Philippe Amouyal Form 4 Trading Tracker

According to the SEC Form 4 filings, Philippe Amouyal has made a total of 1 transactions in Cava Group Inc (CAVA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cava Group Inc is the acquisition of 10,000 shares on November 17, 2023, which cost Philippe Amouyal around $331,800.

According to the SEC Form 4 filings, Philippe Amouyal has made a total of 1 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 200,000 shares on November 13, 2023, which cost Philippe Amouyal around $202,000.

According to the SEC Form 4 filings, Philippe Amouyal has made a total of 0 transactions in WW International Inc (WW) over the past 5 years. The most-recent trade in WW International Inc is the sale of 7,500 shares on August 31, 2018, which brought Philippe Amouyal around $566,925.

Insider Trading History of Philippe Amouyal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Philippe Amouyal Trading Performance

GuruFocus tracks the stock performance after each of Philippe Amouyal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Philippe Amouyal is 116.97%. GuruFocus also compares Philippe Amouyal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Philippe Amouyal within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Philippe Amouyal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Philippe Amouyal

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.49 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.87 LIMIT LIMIT LIMIT LIMIT LIMIT

Philippe Amouyal Ownership Network

Ownership Network List of Philippe Amouyal

No Data

Ownership Network Relation of Philippe Amouyal

Insider Network Chart

Philippe Amouyal Owned Company Details

What does Lexicon Pharmaceuticals Inc do?

Who are the key executives at Lexicon Pharmaceuticals Inc?

Philippe Amouyal is the director of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .

Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary

Over the past 18 months, Philippe Amouyal made 1 insider transaction in Lexicon Pharmaceuticals Inc (LXRX) with a net purchase of 200,000. Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .

In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.

Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lexicon Pharmaceuticals Inc Insider Transactions

No Available Data

Philippe Amouyal Mailing Address

Above is the net worth, insider trading, and ownership report for Philippe Amouyal. You might contact Philippe Amouyal via mailing address: C/o Cava Group, Inc., 14 Ridge Square Nw, Suite 500, Washington Dc 20016.